Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
Our understanding of the genetics and treatment options for primary effusion lymphoma (PEL) is lacking. Here the authors performed in vitro CRISPR/Cas9 knock-out screens to identify 210 PEL-specific oncogenic genes and report strategies for therapeutic intervention.
Guardado en:
Autores principales: | Mark Manzano, Ajinkya Patil, Alexander Waldrop, Sandeep S. Dave, Amir Behdad, Eva Gottwein |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4753b6af0a0c4636a623f9ba180cea46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
por: Mark Manzano, et al.
Publicado: (2020) -
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
por: Chong Wang, et al.
Publicado: (2020) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
por: Hamidreza Aboulkheyr Es, et al.
Publicado: (2021) -
Targeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion Lymphoma
por: Carolina Caro-Vegas, et al.
Publicado: (2019) -
Evolutionarily conserved herpesviral protein interaction networks.
por: Even Fossum, et al.
Publicado: (2009)